Skip to main content
Home
Main navigation
  • Contents
    • Reactions
    • Expert voices
    • What we know
    • Resource library
    • Briefings
    • Training
    • SMC Studies
  • Journalists
  • Scientists
  • Press offices
  • About SMC ES
    • About SMC ES
    • The 5Ws +1
    • Statute
    • Advisory Committee
    • Working Method
    • Governance
    • Team
    • FAQ
  • Global network
User account menu - Secondary
  • ES
  • EN

Breadcrumb

  1. Home
Autor/es reacciones

Paresh Malhotra

Head of the Division of Neurology, Imperial College London; and Consultant Neurologist, Imperial College Healthcare NHS Trust.

Reactions to the approval of lecanemab for the treatment of Alzheimer's patients in the US
EN
Home
Science Media Centre Spain
 
bluesky  
 
Sobre SMC
  • What is the SMC Spain
  • Statute
  • Advisory Committee
  • CC Licence
  • FAQ
Contact the SMC

Do you have any questions or suggestions?

Write to us
Información
  • Legal Notice and Privacy Policy
  • Cookies Policy
  • Accesibilidad
© Science Media Centre 2021